Antibodies used in this study. by Kevin J. Kokesh (19859571)

“…Western blot and densitometric analysis showed a significant increase in cathepsin B protein expression in <i>M</i>. …”

Time and flowrate used for proteomics. by Kevin J. Kokesh (19859571)

“…Western blot and densitometric analysis showed a significant increase in cathepsin B protein expression in <i>M</i>. …”

S1 Graphical abstract - by Kevin J. Kokesh (19859571)

“…Western blot and densitometric analysis showed a significant increase in cathepsin B protein expression in <i>M</i>. …”

Microscopic view of <i>spirulina</i> spp. by Maha Rehman (17114332)

Subjects:

Growth of <i>Spirulina</i> spp. at 450nm for different temperature. by Maha Rehman (17114332)

Subjects:

Fig 5 - by Maha Rehman (17114332)

Subjects:

Fig 3 - by Maha Rehman (17114332)

Subjects:

Supplementary data file of graphs. by Maha Rehman (17114332)

Subjects:

Fig 4 - by Maha Rehman (17114332)

Subjects:

Age-standardized prevalence rates of gynecological diseases across 204 countries and territories in 2021. by Xiaofeng He (2618752)

Subjects:

Age-standardized prevalence rates of gynecological diseases across 21 GBD regions, by SDI, from 1990 to 2021. by Xiaofeng He (2618752)

Subjects:

Estimated annual percentage change in age-standardized prevalence rates of gynecological diseases across 204 countries and territories in 2021. by Xiaofeng He (2618752)

Subjects:

Prevalence and trends of gynecological diseases (GDs) among women of childbearing age, by age group and SDI. by Xiaofeng He (2618752)

Subjects:

Estimated annual percentage changes in the prevalence rate of specific gynecological diseases from 1990 to 2021, categorized by age group and SDI. by Xiaofeng He (2618752)

Subjects:

Prevalence of gynecological diseases (GDs) among women of childbearing age in 2021, along with their changes from 1990 to 2021, and the contribution of each GD to the overall preva... by Xiaofeng He (2618752)

Subjects:

The global prevalence of gynecological diseases among women aged 15-49 years in 1990 and 2021, along with the trends and changes observed between these years. by Xiaofeng He (2618752)

Subjects:

Baseline and post-treatment results of categorical electrocardiographic variables in each study group. by Káryta Suely Macêdo Martins (22404155)

Subjects:

ELISA results in serum indices between the control and diarrhea groups. by Houkang Ding (20968091)

Subjects:

Line graph showing the values of inflammatory cytokines at baseline and after treatment. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Effects of FSAE in rabbits (n by Houkang Ding (20968091)

Subjects: